Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)01069-4
Affiliations:
6
Authors:
9
Go to article
Institutions Authors Share
Lilly, United States of America (USA)
4.000000
 0.44
Centro de Investigaciones Metabolicas (CINME), Argentina
1.000000
 0.11
Texas Diabetes and Endocrinology (TD&E), United States of America (USA)
1.000000
 0.11
Life Care Hospital and Research Centre (LCHRC), India
1.000000
 0.11
Manatí Center for Clinical Research, United States of America (USA)
1.000000
 0.11
Gemeinschaftspraxis für Innere Medizin und Diabetologie, Germany
1.000000
 0.11
Interested in Clinical Sciences?